Company Directory / research
PrivateFor profitresearchBerkeley, United States
Chameleon Biosciences
Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.
- Founded
- 2017 9 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $14M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
9 years old.
Reach
Website ranked #9,123,495 in the world for traffic, about 445 visits a month.
What it does
BiotechnologyGeneticsTherapeutics
Funding, as listed
$14M currency not stated
- Rounds5
- LatestSeed, Nov 2022
- Investors9, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Chameleon Biosciences, field by field. Contact details are held but never shown.
The company
- Name
- Chameleon Biosciences
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Casey Maguire, Genine Winslow
- Industry
- research
- Categories
- Biotechnology, Genetics, Therapeutics
Where
- City
- Berkeley
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 1-10
- Web traffic rank
- #9,123,495
- Monthly web visits
- 445
Funding, as listed
- Total
- 14,200,000 (currency not stated)
- Rounds
- 5
- Latest round
- Seed
- Latest round date
- Nov 2022
- Investors
- 9
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.